Cargando…

Combined obstructive airflow limitation associated with interstitial lung diseases (O-ILD): the bad phenotype ?

BACKGROUND: Patients suffering from combined obstructive and interstitial lung disease (O-ILD) represent a pathological entity which still has to be well clinically described. The aim of this descriptive and explorative study was to describe the phenotype and functional characteristics of a cohort o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guiot, Julien, Henket, Monique, Frix, Anne-Noëlle, Gester, Fanny, Thys, Marie, Giltay, Laurie, Desir, Colin, Moermans, Catherine, Njock, Makon-Sébastien, Meunier, Paul, Corhay, Jean-Louis, Louis, Renaud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996531/ https://www.ncbi.nlm.nih.gov/pubmed/35410260 http://dx.doi.org/10.1186/s12931-022-02006-9

Ejemplares similares

Airflow obstruction as a marker of adverse prognosis in rheumatoid arthritis
por: Guiot, Julien, et al.
Publicado: (2023)

A new nucleosomic-based model to identify and diagnose SSc-ILD
por: Guiot, Julien, et al.
Publicado: (2020)

Progressive fibrosing interstitial lung disease in rheumatoid arthritis: A retrospective study
por: Denis, Anna, et al.
Publicado: (2022)

Single-center experience of patients with interstitial lung diseases during the early days of the COVID-19 pandemic
por: Guiot, J., et al.
Publicado: (2020)

Serum IGFBP-2 in systemic sclerosis as a prognostic factor of lung dysfunction
por: Guiot, Julien, et al.
Publicado: (2021)

Blood Biomarkers in Idiopathic Pulmonary Fibrosis
por: Guiot, Julien, et al.
Publicado: (2017)

Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p
por: Guiot, Julien, et al.
Publicado: (2020)

A Blood Exosomal miRNA Signature in Acute Respiratory Distress Syndrome
por: Parzibut, Gilles, et al.
Publicado: (2021)

Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis
por: Njock, Makon-Sébastien, et al.
Publicado: (2019)

Exosomal Long Non-Coding RNAs in Lung Diseases
por: Poulet, Christophe, et al.
Publicado: (2020)

Sputum biomarkers in IPF: Evidence for raised gene expression and protein level of IGFBP-2, IL-8 and MMP-7
por: Guiot, J., et al.
Publicado: (2017)

Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature
por: Bonhomme, Olivier, et al.
Publicado: (2019)

Systematic review of overlapping microRNA patterns in COVID-19 and idiopathic pulmonary fibrosis
por: Guiot, Julien, et al.
Publicado: (2023)

Editorial: Progressive fibrosing interstitial lung disease: from bench to bedside
por: Guiot, Julien, et al.
Publicado: (2023)

Increased KL-6 levels in moderate to severe COVID-19 infection
por: Cambier, Maureen, et al.
Publicado: (2022)

The Role of Imaging in the Detection of Non-COVID-19 Pathologies during the Massive Screening of the First Pandemic Wave
por: Canivet, Perrine, et al.
Publicado: (2022)

Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD
por: Corhay, Jean Louis, et al.
Publicado: (2014)

Exosomal miRNAs in Lung Diseases: From Biologic Function to Therapeutic Targets
por: Guiot, Julien, et al.
Publicado: (2019)

Inflammatory profile of induced sputum composition in systemic sclerosis and comparison with healthy volunteers
por: Jacquerie, P., et al.
Publicado: (2021)

Are Volatile Organic Compounds Able to Identify Airflow Decline in Asthma?
por: Graff, Sophie, et al.
Publicado: (2021)

Positive Effects of Vitamin D Supplementation in Patients Hospitalized for COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
por: De Niet, Sophie, et al.
Publicado: (2022)

Automatized lung disease quantification in patients with COVID-19 as a predictive tool to assess hospitalization severity
por: Guiot, Julien, et al.
Publicado: (2022)

Asthma and COPD Are Not Risk Factors for ICU Stay and Death in Case of SARS-CoV2 Infection
por: Calmes, Doriane, et al.
Publicado: (2021)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2016)

The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies
por: Fastrès, Aline, et al.
Publicado: (2017)

YKL-40 as a new promising prognostic marker of severity in COVID infection
por: Schoneveld, Lauranne, et al.
Publicado: (2021)

Development and Validation of an Automated Radiomic CT Signature for Detecting COVID-19
por: Guiot, Julien, et al.
Publicado: (2020)

ChILD – Children's interstitial lung disease
Publicado: (2018)

Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians
por: Frix, Anne-Noëlle, et al.
Publicado: (2021)

Diagnosis of Idiopathic Pulmonary Fibrosis in High-Resolution Computed Tomography Scans Using a Combination of Handcrafted Radiomics and Deep Learning
por: Refaee, Turkey, et al.
Publicado: (2022)

Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study
por: Darcis, Gilles, et al.
Publicado: (2021)

Interstitial lung disease (ILD) in India: Insights and lessons from the prospective, landmark ILD-India registry
por: Raghu, Ganesh, et al.
Publicado: (2016)

Impact of progressive fibrosing interstitial lung disease (ILD) in ILD patients complicated with secondary spontaneous pneumothorax
por: Yamakawa, Hideaki, et al.
Publicado: (2021)

Role of Autoantibodies in the Diagnosis of Connective-Tissue Disease ILD (CTD-ILD) and Interstitial Pneumonia with Autoimmune Features (IPAF)
por: Jee, Adelle S., et al.
Publicado: (2017)

Could KL-6 levels in COVID-19 help to predict lung disease?
por: Frix, AN, et al.
Publicado: (2020)

CCL18 as a Biomarker of Interstitial Lung Disease (ILD) and Progressive Fibrosing ILD in Patients with Idiopathic Inflammatory Myopathies
por: Zanatta, Elisabetta, et al.
Publicado: (2023)

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)
por: Cottin, Vincent, et al.
Publicado: (2019)

Children’s Interstitial and Diffuse Lung Diseases (ChILD) in 2020
por: Ferraro, Valentina Agnese, et al.
Publicado: (2020)

Management of Progressive Fibrosing Interstitial Lung Diseases (PF-ILD)
por: Copeland, Carla R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2lbems6lco0fk7rem4rvdg660n